Heart diseases Trials in Los Angeles, United States
Conditions / Heart diseases / Los Angeles, United States
Heart diseases has been the subject of sustained clinical investigation across multiple research sites.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02351726 | Mitroflow DL Post Approval Study- North America | TERMINATED | NA |
| NCT06563895 | Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant | RECRUITING | PHASE3 |
| NCT00094302 | Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function | COMPLETED | PHASE3 |
| NCT03860935 | Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy | COMPLETED | PHASE3 |
| NCT01471522 | International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) | COMPLETED | NA |
| NCT04124120 | Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | RECRUITING | NA |
| NCT00047437 | Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure | COMPLETED | PHASE3 |
| NCT01464476 | Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) | TERMINATED | PHASE3 |
| NCT03142152 | The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR | RECRUITING | NA |
| NCT04591392 | Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD | ACTIVE_NOT_RECRUITING | NA |